Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Xiling Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4978-3531; OpenAlex author ID A5023687769; NIH RePORTER profile ID 9851569. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
1
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 grant

Papers 2

  1. CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-25-1201↗
  2. The KRAS tour: Studying metabolic reprogramming in isogenic pancreatic cancer organoids. First author DOI 10.1016/j.stem.2023.12.010↗

Grants 1

  1. Deciphering the Brain–Liver Axis in Cancer-Associated Cachexia R01CA315660↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shree Bose · 1 shared paper, 2024 · strength 0.46
  2. Liang Wang · 1 shared paper, 2025 · strength 0.30
  3. Daoyan Wei · 1 shared paper, 2025 · strength 0.30
  4. Yi Liu · 1 shared paper, 2025 · strength 0.30
  5. Xiangsheng Zuo · 1 shared paper, 2025 · strength 0.30
  6. Robert S. Bresalier · 1 shared paper, 2025 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.